Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,412,394
-
Total 13F shares
-
18,787,112
-
Share change
-
-1,100,668
-
Total reported value
-
$775,920,001
-
Put/Call ratio
-
73%
-
Price per share
-
$41.30
-
Number of holders
-
153
-
Value change
-
-$48,861,238
-
Number of buys
-
93
-
Number of sells
-
63
Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q1 2021
As of 31 Mar 2021,
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,787,112 shares.
The largest 10 holders included
ARK Investment Management LLC, FEDERATED HERMES, INC., BlackRock Inc., STATE STREET CORP, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, FMR LLC, Bank Julius Baer & Co. Ltd, Zurich, TWO SIGMA INVESTMENTS, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
153
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.